insights_auto
Why is 4AB up 3,29%?
Dive Deeperchevron_right
4AB:ETR
AbbVie Common Stock
244,60 €
arrow_upward
+3,29%(+7,80) 1D
7-окт., 17:35:41 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
238,20 €
High
244,60 €
Low
238,00 €
Mkt. cap
479,52 млд
Avg. vol.
672,00
Volume
352,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
Open
238,20 €
High
244,60 €
Low
238,00 €
Mkt. cap
479,52 млд
Avg. vol.
672,00
Volume
352,00
52-wk high
244,60 €
52-wk low
162,85 €
No. of employees
57 миң
News stories
From web sources and news partners
Insider Monkey
·
1 саат мурун
Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?
Investing.com
·
3 саат мурун
AbbVie options flow shows 4:1 call-to-put ratio as stock rises
Yahoo Finance
·
4 саат мурун
Update: AbbVie Shares Rise After FDA Gives 2 Breakthrough Designations for Cancer Drug
AD HOC NEWS
·
8 саат мурун
AbbVie stock gains 2.25 percent before October earnings date
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 миң
Founded2012-ж., 10-апр.
HeadquartersСевер Чикаго, Иллинойс, Америка Кошмо Штаттары
Sector-
Websiteabbvie.com